In summary, ITM2B truncation‐triggered active caspase‐7 migracytosis hyperactivates the IL‐6 pathway in RCC, eventually resulting in a feedback effect that exacerbates RCC progression. This evidence concerns the gene IL6 and renal cell carcinoma.